Semaglutide UK — 9 proven facts you need to know.
Semaglutide UK interest keeps growing, with more brands, doses and formats than ever. Wegovy, Ozempic, Rybelsus and the new Wegovy pill all contain the same active ingredient, which makes choosing between them confusing.
This semaglutide UK guide explains how the medicine works, each brand and dose, weight loss results, prices, NHS access, side effects and how it compares with tirzepatide and retatrutide. It also covers generics, compounded versions and research products, so you know exactly what is licensed.
Wegovy is the licensed semaglutide for weight management in the UK. See doses, pricing and support.
Explore Wegovy →What is semaglutide?
Semaglutide is a medicine made by Novo Nordisk that copies a natural gut hormone called GLP-1. It was first developed for type 2 diabetes and is now one of the most widely used weight loss medicines in the world.
For semaglutide UK patients, it comes under several brand names, as weekly injections or daily tablets. Each brand has its own licence, doses and uses.
The NHS guidance on semaglutide explains how it is used, who it suits and what to expect.
How semaglutide works
For semaglutide UK users, the mechanism explains both the benefits and the side effects. Semaglutide activates the GLP-1 receptor, the same pathway your body uses after a meal. It signals fullness to the brain, slows how quickly your stomach empties and helps the pancreas release insulin when blood sugar rises.
The result is less hunger, smaller portions and fewer cravings. Many people say the constant background thinking about food becomes much quieter.
Semaglutide targets one hormone pathway (GLP-1). Tirzepatide targets two and retatrutide targets three, which is why their average weight loss differs.
Semaglutide UK brands explained
Semaglutide UK supply comes in four licensed forms. The brand you are prescribed depends on whether treatment is for weight management or diabetes.
| Brand | Form | Licensed for | Usual top dose |
|---|---|---|---|
| Wegovy | Weekly injection pen | Weight management | 2.4mg (7.2mg higher dose also approved) |
| Wegovy pill | Daily tablet | Weight management | 25mg tablet |
| Ozempic | Weekly injection pen | Type 2 diabetes | 2mg |
| Rybelsus | Daily tablet | Type 2 diabetes | 14mg |
Wegovy and Ozempic are compared in detail in our Ozempic vs Wegovy guide. For tablets, see our oral semaglutide tablet and Wegovy pill vs pen guides.
Semaglutide UK: 9 proven facts
1. It is sold under several brands
Wegovy, the Wegovy pill, Ozempic and Rybelsus all contain semaglutide.
2. It targets the GLP-1 hormone
This single pathway reduces appetite and improves blood sugar control.
3. Injections are weekly, tablets daily
Wegovy and Ozempic pens are used once a week; Wegovy tablets and Rybelsus are taken every morning.
4. Doses rise slowly
Wegovy starts at 0.25mg and increases every four weeks to 2.4mg.
5. Average weight loss is about 15%
In STEP-1, Wegovy 2.4mg produced about 14.9% average weight loss over 68 weeks.
6. A higher 7.2mg dose is now approved
The MHRA has approved a higher Wegovy dose for some patients who need more weight loss.
7. A daily pill is now available
The Wegovy pill launched in the UK as the first daily oral GLP-1 for weight management.
8. It also protects the heart
The SELECT trial found Wegovy reduced the risk of heart attack, stroke and cardiovascular death in people with heart disease and excess weight.
9. There is no UK generic yet
Semaglutide UK patents are expected to run until around 2031, though generics have started in other countries.
Wegovy dose schedule
Semaglutide UK prescriptions for weight management usually follow this step-up schedule. Slow increases help your body adjust and reduce side effects.
| Weeks | Wegovy dose |
|---|---|
| 1–4 | 0.25mg |
| 5–8 | 0.5mg |
| 9–12 | 1mg |
| 13–16 | 1.7mg |
| 17 onwards | 2.4mg maintenance dose |
Some people stay on a lower dose if they are losing weight well or struggling with side effects. See our Wegovy dosing schedule and how to inject Wegovy guides for full detail.
Weight loss results
Results are why semaglutide UK demand is so high. In STEP-1, adults without diabetes lost an average of about 14.9% of their body weight over 68 weeks on Wegovy 2.4mg, compared with about 2.4% on placebo. Around a third lost 20% or more.
Most weight comes off in the first year, then progress slows. People with type 2 diabetes usually lose a little less on average.
For realistic timelines, see our Wegovy weight loss results and how long Wegovy takes to work guides, plus your first week on semaglutide.
Prices and value
Semaglutide UK prices vary by brand, dose and pharmacy. Wegovy pens are priced by strength, while the Wegovy pill has its own pricing structure.
Our Wegovy pill UK price and availability guide compares current tablet prices. You can also see pricing and support on our Wegovy product page.
Shopping around between regulated pharmacies can make a noticeable difference to monthly costs, especially on higher doses.
NHS access
NHS access shapes many semaglutide UK decisions. NICE recommends Wegovy on the NHS for some adults with obesity, usually through specialist weight management services and for up to two years. Waiting lists can be long, and criteria are stricter than for private prescriptions.
Ozempic is prescribed on the NHS for type 2 diabetes, not for weight loss alone. That is why most semaglutide UK users seeking weight management pay privately.
Side effects and safety
Side effects are a common semaglutide UK question. Most affect the digestive system and are strongest when starting or increasing the dose.
- Nausea, especially after large or fatty meals
- Diarrhoea or constipation
- Vomiting and stomach discomfort
- Bloating, burping and reflux
- Tiredness and headaches in the early weeks
Semaglutide is not suitable during pregnancy or breastfeeding, or for people with a personal or family history of medullary thyroid cancer or MEN2. Get urgent help for severe, persistent stomach pain, which can be a sign of pancreatitis. Stop treatment at least two months before trying to conceive.
See our Wegovy side effects and Ozempic side effects guides, and our explainer on Ozempic face.
How semaglutide compares with other GLP-1 medicines
| Medicine | Hormones targeted | Typical average weight loss (top dose) | UK status |
|---|---|---|---|
| Semaglutide (Wegovy) | GLP-1 | About 14.9% in STEP-1 | Licensed |
| Tirzepatide (Mounjaro) | GLP-1 + GIP | About 20.9% in SURMOUNT-1 | Licensed |
| Retatrutide | GLP-1 + GIP + glucagon | 25.0% at 80 weeks in TRIUMPH-1 | Not yet approved |
For full comparisons, see Wegovy vs Mounjaro, retatrutide vs semaglutide and our tirzepatide UK guide.
Generic semaglutide and patents
Semaglutide patents began expiring in 2026 in several countries, including Canada, India, China and Brazil, and generic versions have started to launch there. This has made semaglutide much cheaper in those markets.
In the UK and Europe, patent protection is expected to last until around 2031. Until then, semaglutide UK supply remains branded Wegovy, Ozempic and Rybelsus.
Compounded and research semaglutide
In the US, compounded semaglutide was made by pharmacies during shortages, but this isn’t a licensed route in the UK. Research semaglutide sold online in vials is not approved for human use.
These products are not checked by the MHRA, and fake semaglutide pens have been found in the UK. For human use, semaglutide UK patients should use licensed brands from a regulated pharmacy; our research peptides UK legal guide explains why.
Who can use semaglutide?
Wegovy is licensed for adults with a BMI of 30 or more, or 27 to 30 with a weight-related health condition such as high blood pressure, type 2 diabetes or sleep apnoea. A prescriber checks your suitability first.
Semaglutide UK prescribers also review your other medicines, medical history and pregnancy plans. It may not be suitable if you have had pancreatitis or certain thyroid cancers.
Buying safely
Rising demand has attracted unsafe sellers online. Buying semaglutide UK products safely means using a regulated pharmacy and a proper prescription.
- Use a pharmacy registered with the General Pharmaceutical Council (GPhC)
- Expect a health consultation before you are prescribed
- Avoid social media sellers and messaging apps
- Be wary of prices far below normal
- Check for sealed, UK-labelled Wegovy or Ozempic packaging
Heart health benefits
Semaglutide is the first weight loss medicine shown to cut heart risk in a major trial. In SELECT, Wegovy reduced heart attacks, strokes and cardiovascular deaths by about 20% in adults with heart disease and excess weight.
This makes semaglutide UK treatment relevant beyond weight alone, especially for people with existing heart disease. See our guide to GLP-1 and heart health.
Semaglutide for type 2 diabetes
Ozempic and Rybelsus are licensed for type 2 diabetes. They lower blood sugar, help with weight and, in trials, reduced some heart and kidney risks.
Many semaglutide UK diabetes patients get Ozempic on the NHS. Using Ozempic purely for weight loss is off-label; our Ozempic for weight loss guide explains the difference.
Switching between brands
Some people move between semaglutide brands, for example from Wegovy injections to the Wegovy pill. Doses are not directly interchangeable, so switching must be guided by a prescriber.
Others switch from semaglutide to tirzepatide if weight loss stalls. Semaglutide UK prescribers usually choose a new starting dose based on your current dose and side effects.
Stopping semaglutide and weight regain
Semaglutide is designed for long-term use. In the STEP-1 extension, people who stopped regained around two-thirds of the weight they had lost within a year.
That doesn’t mean treatment has failed; it shows obesity is a long-term condition. Building habits during treatment helps, and semaglutide UK prescribers can advise on reducing the dose gradually.
Supply and availability
Shortages affected Ozempic and Wegovy in 2023 and 2024, partly because of huge global demand. Supply has since improved, and most semaglutide UK pharmacies now stock the main strengths.
If a dose is out of stock, speak to your pharmacy or prescriber rather than buying from an unregulated source.
Travelling with semaglutide
Pens can travel in hand luggage with a cool bag, but keep them away from direct heat and never put them in the hold. Carry your prescription or a pharmacy letter in case you are asked about it.
If you cross time zones, try to keep your weekly injection on the same day, adjusting by a few hours if needed. Tablets should still be taken on an empty stomach each morning.
Getting the best results
Semaglutide UK users get the best results alongside healthy habits. Protein, fibre, hydration and strength training help you lose fat while protecting muscle.
- Eat protein at every meal
- Choose smaller portions and eat slowly
- Drink plenty of water
- Add resistance exercise two or three times a week
- Keep alcohol low, as it can worsen nausea
See our best diet on Wegovy, GLP-1 and muscle loss and Wegovy and alcohol guides.
When progress slows
Many semaglutide UK users see weight loss slow after six to twelve months. This is normal as your body adapts.
Reviewing protein, activity and dose with your prescriber usually helps. Some people later switch to tirzepatide. Our Wegovy plateau guide covers next steps.
Storage and practical tips
Good storage protects your semaglutide UK supply. Keep unused Wegovy and Ozempic pens in the fridge between 2°C and 8°C and never freeze them. Check the leaflet for how long a pen can be kept at room temperature.
Take Wegovy tablets exactly as directed, on an empty stomach with a small sip of water. See our how to take the Wegovy pill correctly and storing GLP-1 medications guides.
Which form should you choose?
Choosing between semaglutide UK options usually comes down to your goal, routine and comfort with injections. Your prescriber will help you decide.
- Wegovy pen: best for most people seeking weight management, with the strongest weight loss data and a once-weekly routine
- Wegovy pill: suits people who dislike injections and can take a tablet on an empty stomach every morning
- Ozempic: for adults with type 2 diabetes, often available on the NHS
- Rybelsus: a daily tablet for type 2 diabetes
Not sure which semaglutide UK option fits? Compare our Wegovy, Wegovy pill and Ozempic product pages, or speak to our team.
Key takeaways
- Semaglutide UK supply comes as Wegovy, the Wegovy pill, Ozempic and Rybelsus
- It targets GLP-1, giving about 14.9% average weight loss on Wegovy 2.4mg
- Wegovy doses start at 0.25mg and rise every four weeks to 2.4mg
- Semaglutide UK prices vary by brand and pharmacy, so compare regulated providers
- There is no UK generic, and compounded or research versions are not licensed
The safest semaglutide UK route is a licensed brand from a regulated pharmacy, used alongside healthy eating, activity and good sleep. If you are unsure which option suits you, our team can help you compare.
Semaglutide changed weight management in the UK. Today, the choice is not just whether to use it, but which licensed form suits your life best.
Mymetabolism TeamCommon questions — Semaglutide UK
Explore Wegovy with Mymetabolism.
Licensed semaglutide with transparent UK pricing and support from the Mymetabolism team.
Explore Wegovy →